Claudia Campana

Digital quantification of somatostatin receptor subtype 2a immunostaining: a validation study

P. V. van Koetsveld, L. Hofland, W. D. de Herder, 2022, European journal of endocrinology.

Emerging drugs for the treatment of acromegaly

Giuliana Corica, Giulia Graziani, D. Ferone, 2020, Expert opinion on emerging drugs.

Octreotide and Pasireotide Combination Treatment in Somatotroph Tumor Cells: Predominant Role of SST2 in Mediating Ligand Effects

A. Bajetto, T. Florio, F. Barbieri, 2021, Cancers.

Anti-Müllerian hormone in pre-menopausal females after ablative radioiodine treatment for differentiated thyroid cancer

M. Mussap, S. Gay, M. Giusti, 2018, Endocrine.

Clinical and Radiological Predictors of Biochemical Response to First-Line Treatment With Somatostatin Receptor Ligands in Acromegaly: A Real-Life Perspective

G. Zoppoli, Giuliana Corica, D. Ferone, 2021, Frontiers in Endocrinology.

Discordant GH and IGF-1 results in treated acromegaly: impact of GH cut-offs and mean values assessment.

Giuliana Corica, D. Ferone, G. Zona, 2020, The Journal of clinical endocrinology and metabolism.

Treatment of Type 2 Diabetes in Subjects with Obesity: What is the Best Approach?

D. Ferone, F. Gatto, E. Monti, 2020, Interventions in Obesity & Diabetes.

Current perspectives on the impact of clinical disease and biochemical control on comorbidities and quality of life in acromegaly

Giuliana Corica, M. Giusti, D. Ferone, 2019, Reviews in Endocrine and Metabolic Disorders.

Low-Salt Intake Suggestions in Hypertensive Patients Do not Jeopardize Urinary Iodine Excretion

M. Giusti, N. Musso, C. Campana, 2018, Nutrients.